pembrolizumab
merck
['melanoma', 'pembro']
with the data from swog s1801 on adjuvant vs neoadjuvant pembrolizumab for resected stage iii-iv melanoma just presented at #esmo22, this recent viewpoint article seems particularly relevant: 
The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.